{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:48:00Z","timestamp":1792511280132,"version":"4.5.0"},"reference-count":129,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.xcrm.2026.102992","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:31:08Z","timestamp":1787067068000},"page":"102992","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The evolution of iPSC-based cell therapy across autologous and allogeneic pathways"],"prefix":"10.1016","volume":"7","author":[{"given":"Anmin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongkui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7405-8473","authenticated-orcid":false,"given":"Mingxia","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102992_bib1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102992_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41576-019-0100-z","article-title":"Induced pluripotent stem cells in disease modelling and drug discovery","volume":"20","author":"Rowe","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.xcrm.2026.102992_bib3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","article-title":"Pluripotent Stem Cell-Based Cell Therapy-Promise and Challenges","volume":"27","author":"Yamanaka","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.102992_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.stem.2022.01.007","article-title":"iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders","volume":"29","author":"Okano","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.102992_bib5","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jcyt.2025.01.015","article-title":"iPSC-based cell replacement therapy: from basic research to clinical application","volume":"27","author":"Takahashi","year":"2025","journal-title":"Cytotherapy"},{"key":"10.1016\/j.xcrm.2026.102992_bib6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102992_bib7","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102992_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nature06534","article-title":"Reprogramming of human somatic cells to pluripotency with defined factors","volume":"451","author":"Park","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102992_bib9","doi-asserted-by":"crossref","first-page":"796","DOI":"10.7150\/ijbs.6.796","article-title":"Applications of patient-specific induced pluripotent stem cells; focused on disease modeling, drug screening and therapeutic potentials for liver disease","volume":"6","author":"Chun","year":"2010","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.xcrm.2026.102992_bib10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3858\/emm.2012.44.3.015","article-title":"Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery","volume":"44","author":"Jang","year":"2012","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.xcrm.2026.102992_bib11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41392-024-01809-0","article-title":"Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications","volume":"9","author":"Cerneckis","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2026.102992_bib12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/jcm3020373","article-title":"The Power and the Promise of Cell Reprogramming: Personalized Autologous Body Organ and Cell Transplantation","volume":"3","author":"Palomo","year":"2014","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.xcrm.2026.102992_bib13","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1126\/science.1105063","article-title":"Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking","volume":"308","author":"Kustikova","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102992_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1627149","article-title":"Clinical translation of human iPSC technologies: advances, safety concerns, and future directions","volume":"13","author":"Dhaiban","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.xcrm.2026.102992_bib15","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1089\/scd.2013.0621","article-title":"Vectorology and factor delivery in induced pluripotent stem cell reprogramming","volume":"23","author":"Hu","year":"2014","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.xcrm.2026.102992_bib16","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.stem.2016.06.017","article-title":"Molecular Obstacles to Clinical Translation of iPSCs","volume":"19","author":"Tapia","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.102992_bib17","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJMoa1608368","article-title":"Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration","volume":"376","author":"Mandai","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102992_bib18","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.oret.2019.04.021","article-title":"Evaluation of Transplanted Autologous Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium in Exudative Age-Related Macular Degeneration","volume":"3","author":"Takagi","year":"2019","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.xcrm.2026.102992_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s41232-019-0106-0","article-title":"Overview: an iPS cell stock at CiRA","volume":"39","author":"Umekage","year":"2019","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.xcrm.2026.102992_bib20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","article-title":"Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients","volume":"37","author":"Deuse","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102992_bib21","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.stem.2023.08.001","article-title":"Chemical reprogramming for cell fate manipulation: Methods, applications, and perspectives","volume":"30","author":"Wang","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.102992_bib22","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.tibs.2025.03.004","article-title":"Decoding human chemical reprogramming: mechanisms and principles","volume":"50","author":"Cheng","year":"2025","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.xcrm.2026.102992_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.gde.2018.05.004","article-title":"Small molecule-induced cellular fate reprogramming: promising road leading to Rome","volume":"52","author":"Li","year":"2018","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.xcrm.2026.102992_bib24","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41587-026-03105-4","article-title":"World's first two iPSC therapies in Japan","volume":"44","year":"2026","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102992_bib25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature10135","article-title":"Immunogenicity of induced pluripotent stem cells","volume":"474","author":"Zhao","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102992_bib26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nature09805","article-title":"Somatic coding mutations in human induced pluripotent stem cells","volume":"471","author":"Gore","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102992_bib27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature09871","article-title":"Copy number variation and selection during reprogramming to pluripotency","volume":"471","author":"Hussein","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102992_bib28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.stem.2010.12.003","article-title":"Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture","volume":"8","author":"Laurent","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.102992_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005932","article-title":"Mutational History of a Human Cell Lineage from Somatic to Induced Pluripotent Stem Cells","volume":"12","author":"Rouhani","year":"2016","journal-title":"PLoS Genet."},{"key":"10.1016\/j.xcrm.2026.102992_bib30","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1164270","article-title":"Generation of mouse induced pluripotent stem cells without viral vectors","volume":"322","author":"Okita","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102992_bib31","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.1162494","article-title":"Induced pluripotent stem cells generated without viral integration","volume":"322","author":"Stadtfeld","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102992_bib32","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2183\/pjab.85.348","article-title":"Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome","volume":"85","author":"Fusaki","year":"2009","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"10.1016\/j.xcrm.2026.102992_bib33","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nature07863","article-title":"piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells","volume":"458","author":"Woltjen","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102992_bib34","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","article-title":"Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA","volume":"7","author":"Warren","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.102992_bib35","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1126\/science.1239278","article-title":"Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds","volume":"341","author":"Hou","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102992_bib36","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.stem.2012.02.013","article-title":"Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives","volume":"10","author":"Nazor","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.102992_bib37","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.stem.2026.02.003","article-title":"Two decades of induced pluripotent stem cell research: From discovery to diverse applications","volume":"33","author":"Yamanaka","year":"2026","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.102992_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41536-025-00407-0","article-title":"Allogeneic RPE cell suspension manufactured at scale demonstrating preclinical safety and efficacy led to IND approval","volume":"10","author":"Soundararajan","year":"2025","journal-title":"npj Regen. Med."},{"key":"10.1016\/j.xcrm.2026.102992_bib39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.stemcr.2013.12.007","article-title":"Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application","volume":"2","author":"Kamao","year":"2014","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102992_bib40","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neulet.2009.04.035","article-title":"Generation of retinal cells from mouse and human induced pluripotent stem cells","volume":"458","author":"Hirami","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.xcrm.2026.102992_bib41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.21037\/atm-20-4707","article-title":"Transplantation of GMP-grade human iPSC-derived retinal pigment epithelial cells in rodent model: the first pre-clinical study for safety and efficacy in China","volume":"9","author":"Zhang","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.102992_bib42","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","article-title":"Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease","volume":"382","author":"Schweitzer","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102992_bib43","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/s41587-019-0227-7","article-title":"De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans","volume":"37","author":"Deuse","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102992_bib44","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature11807","article-title":"Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells","volume":"494","author":"Araki","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102992_bib45","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.stem.2013.01.006","article-title":"Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells","volume":"12","author":"Guha","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.102992_bib46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.stem.2015.01.018","article-title":"Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease","volume":"16","author":"Hallett","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.102992_bib47","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.celrep.2013.02.016","article-title":"Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain","volume":"3","author":"Emborg","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102992_bib48","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41591-021-01257-1","article-title":"Autologous transplant therapy alleviates motor and depressive behaviors in parkinsonian monkeys","volume":"27","author":"Tao","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102992_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/celldisc.2015.12","article-title":"Autologous iPSC-derived dopamine neuron transplantation in a nonhuman primate Parkinson's disease model","volume":"1","author":"Wang","year":"2015","journal-title":"Cell Discov."},{"key":"10.1016\/j.xcrm.2026.102992_bib50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.stemcr.2013.08.007","article-title":"Direct comparison of autologous and allogeneic transplantation of iPSC-derived neural cells in the brain of a non-human primate","volume":"1","author":"Morizane","year":"2013","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102992_bib51","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nri1332","article-title":"Clinical islet transplantation: advances and immunological challenges","volume":"4","author":"Ricordi","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.102992_bib52","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nbt0915-890","article-title":"RIKEN suspends first clinical trial involving induced pluripotent stem cells","volume":"33","author":"Garber","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102992_bib53","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041308","article-title":"iPSC-RPE in Retinal Degeneration: Recent Advancements and Future Perspectives","volume":"13","author":"Maeda","year":"2023","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.xcrm.2026.102992_bib54","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.jcyt.2024.05.022","article-title":"Considerations for the development of iPSC-derived cell therapies: a review of key challenges by the JSRM-ISCT iPSC Committee","volume":"26","author":"Madrid","year":"2024","journal-title":"Cytotherapy"},{"key":"10.1016\/j.xcrm.2026.102992_bib55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.medj.2022.10.003","article-title":"A clinical-grade HLA haplobank of human induced pluripotent stem cells matching approximately 40% of the Japanese population","volume":"4","author":"Yoshida","year":"2023","journal-title":"Med"},{"key":"10.1016\/j.xcrm.2026.102992_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2020.102033","article-title":"CiRA iPSC seed stocks (CiRA's iPSC Stock Project)","volume":"50","author":"Hanatani","year":"2021","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.xcrm.2026.102992_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9072217","article-title":"HLA-Matched Allogeneic iPS Cells-Derived RPE Transplantation for Macular Degeneration","volume":"9","author":"Sugita","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.xcrm.2026.102992_bib58","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2217\/rme-2018-0095","article-title":"Quality control guidelines for clinical-grade human induced pluripotent stem cell lines","volume":"13","author":"Sullivan","year":"2018","journal-title":"Regen. Med."},{"key":"10.1016\/j.xcrm.2026.102992_bib59","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.stem.2012.07.014","article-title":"Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types","volume":"11","author":"Taylor","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.102992_bib60","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1089\/scd.2012.0088","article-title":"Haplotype-based banking of human pluripotent stem cells for transplantation: potential and limitations","volume":"21","author":"Zimmermann","year":"2012","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.xcrm.2026.102992_bib61","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41232-021-00190-7","article-title":"Evaluation of immunosuppression protocols for MHC-matched allogeneic iPS cell-based transplantation using a mouse skin transplantation model","volume":"42","author":"Kamatani","year":"2022","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.xcrm.2026.102992_bib62","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41587-023-01784-x","article-title":"Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques","volume":"42","author":"Hu","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102992_bib63","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41591-021-01645-7","article-title":"Human pluripotent stem-cell-derived islets ameliorate diabetes in non-human primates","volume":"28","author":"Du","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102992_bib64","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1038\/s41467-020-17165-w","article-title":"Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson's disease","volume":"11","author":"Doi","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102992_bib65","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1056\/NEJMoa2503822","article-title":"Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression","volume":"393","author":"Carlsson","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102992_bib66","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.stemcr.2015.05.002","article-title":"KeyGenes, a Tool to Probe Tissue Differentiation Using a Human Fetal Transcriptional Atlas","volume":"4","author":"Roost","year":"2015","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102992_bib67","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41551-021-00730-z","article-title":"Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells","volume":"5","author":"Wang","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2026.102992_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1182209","article-title":"Safety confirmation of induced pluripotent stem cell-derived cardiomyocyte patch transplantation for ischemic cardiomyopathy: first three case reports","volume":"10","author":"Kawamura","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.xcrm.2026.102992_bib69","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(24)02462-0","article-title":"Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial","volume":"405","author":"Ghobadi","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2026.102992_bib70","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41586-025-08700-0","article-title":"Phase I\/II trial of iPS-cell-derived dopaminergic cells for Parkinson's disease","volume":"641","author":"Sawamoto","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102992_bib71","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/cr.2015.96","article-title":"Bromodeoxyuridine promotes full-chemical induction of mouse pluripotent stem cells","volume":"25","author":"Long","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.xcrm.2026.102992_bib72","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.stem.2018.03.005","article-title":"Chromatin Accessibility Dynamics during Chemical Induction of Pluripotency","volume":"22","author":"Cao","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.102992_bib73","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.stemcr.2018.05.003","article-title":"Dynamics of Telomere Rejuvenation during Chemical Induction to Pluripotent Stem Cells","volume":"11","author":"Fu","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102992_bib74","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41419-017-0234-x","article-title":"Genome-wide DNA methylation analysis reveals that mouse chemical iPSCs have closer epigenetic features to mESCs than OSKM-integrated iPSCs","volume":"9","author":"Ping","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2026.102992_bib75","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.molcel.2019.01.042","article-title":"Resolving Cell Fate Decisions during Somatic Cell Reprogramming by Single-Cell RNA-Seq","volume":"73","author":"Guo","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2026.102992_bib76","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1016\/j.celrep.2019.11.080","article-title":"Functional Oocytes Derived from Granulosa Cells","volume":"29","author":"Tian","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102992_bib77","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106771","article-title":"Inhibition of Syk promotes chemical reprogramming of fibroblasts via metabolic rewiring and H(2) S production","volume":"40","author":"Wang","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.xcrm.2026.102992_bib78","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/s41556-023-01193-x","article-title":"A fast chemical reprogramming system promotes cell identity transition through a diapause-like state","volume":"25","author":"Chen","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.xcrm.2026.102992_bib79","article-title":"Transcriptome-based chemical screens identify CDK8 as a common barrier in multiple cell reprogramming systems","volume":"42","author":"Li","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102992_bib80","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41536-024-00387-7","article-title":"Transplantation of derivative retinal organoids from chemically induced pluripotent stem cells restored visual function","volume":"9","author":"Zhao","year":"2024","journal-title":"npj Regen. Med."},{"key":"10.1016\/j.xcrm.2026.102992_bib81","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41586-022-04593-5","article-title":"Chemical reprogramming of human somatic cells to pluripotent stem cells","volume":"605","author":"Guan","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102992_bib82","article-title":"Chemical-induced epigenome resetting for regeneration program activation in human cells","volume":"42","author":"Wang","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102992_bib83","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.stem.2024.10.001","article-title":"Generation of human expandable limb-bud-like progenitors via chemically induced dedifferentiation","volume":"31","author":"Zhu","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.102992_bib84","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41421-025-00852-7","article-title":"Robust generation of clinically applicable human pluripotent stem cells from peripheral blood by chemical reprogramming","volume":"11","author":"Fu","year":"2025","journal-title":"Cell Discov."},{"key":"10.1016\/j.xcrm.2026.102992_bib85","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41422-025-01216-2","article-title":"Efficient chemical reprogramming of human T cells to pluripotent stem cells","volume":"36","author":"Wang","year":"2026","journal-title":"Cell Res."},{"key":"10.1016\/j.xcrm.2026.102992_bib86","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.stem.2025.07.003","article-title":"Chemical reprogramming of human blood cells to pluripotent stem cells","volume":"32","author":"Peng","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.102992_bib87","article-title":"Efficient generation of human pluripotent stem cells from frozen cord tissue via chemical reprogramming","author":"Nansubuga","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2026.102992_bib88","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13619-026-00295-9","article-title":"Generation of human chemically induced pluripotent stem cells from UC-MSCs","volume":"15","author":"Gong","year":"2026","journal-title":"Cell Regen."},{"key":"10.1016\/j.xcrm.2026.102992_bib89","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13785","article-title":"A Chemical Reprogramming Approach Efficiently Producing Human Retinal Pigment Epithelium Cells for Retinal Disease Therapies","volume":"58","author":"Zhang","year":"2025","journal-title":"Cell Prolif."},{"key":"10.1016\/j.xcrm.2026.102992_bib90","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-026-03841-w","article-title":"Non-gene-edited neural stem cells reverse neuroinflammation and microbiota dysbiosis in a sprague-dawley rat model of autism spectrum disorder","volume":"16","author":"Liu","year":"2026","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.xcrm.2026.102992_bib91","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41392-022-01109-5","article-title":"Back to pluripotency: fully chemically induced reboot of human somatic cells","volume":"7","author":"Lange","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2026.102992_bib92","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/ijms17020226","article-title":"Chemically Induced Reprogramming of Somatic Cells to Pluripotent Stem Cells and Neural Cells","volume":"17","author":"Biswas","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2026.102992_bib93","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/cr.2015.142","article-title":"Pluripotent stem cells induced from mouse neural stem cells and small intestinal epithelial cells by small molecule compounds","volume":"26","author":"Ye","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.xcrm.2026.102992_bib94","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.cell.2015.11.017","article-title":"A XEN-like State Bridges Somatic Cells to Pluripotency during Chemical Reprogramming","volume":"163","author":"Zhao","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102992_bib95","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.stem.2018.05.025","article-title":"Single-Cell RNA-Seq Reveals Dynamic Early Embryonic-like Programs during Chemical Reprogramming","volume":"23","author":"Zhao","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.102992_bib96","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.stem.2017.05.019","article-title":"Direct Reprogramming of Fibroblasts via a Chemically Induced XEN-like State","volume":"21","author":"Li","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.102992_bib97","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.stem.2023.02.008","article-title":"Highly efficient and rapid generation of human pluripotent stem cells by chemical reprogramming","volume":"30","author":"Liuyang","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.102992_bib98","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/s41589-024-01799-8","article-title":"A rapid chemical reprogramming system to generate human pluripotent stem cells","volume":"21","author":"Wang","year":"2025","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.xcrm.2026.102992_bib99","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1016\/j.cell.2026.03.038","article-title":"p53 safeguards chemical reprogramming of human somatic cells toward pluripotency","volume":"189","author":"Cheng","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102992_bib101","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13540","article-title":"The efficient generation of functional human hepatocytes from chemically induced pluripotent stem cells","volume":"57","author":"Lv","year":"2024","journal-title":"Cell Prolif."},{"key":"10.1016\/j.xcrm.2026.102992_bib102","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1136\/gutjnl-2024-333885","article-title":"Bioprinting functional hepatocyte organoids derived from human chemically induced pluripotent stem cells to treat liver failure","volume":"74","author":"Li","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.xcrm.2026.102992_bib103","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.stem.2025.07.006","article-title":"Reconstruction of endocrine subtype-complete human pluripotent stem cell-derived islets with capacity for hypoglycemia protection in vivo","volume":"32","author":"Meng","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.102992_bib104","article-title":"Generation of dual-attribute iTNK cells from hPSCs for cancer immunotherapy","volume":"4","author":"Zhang","year":"2024","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.xcrm.2026.102992_bib105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40164-025-00613-y","article-title":"TLR7\/8 signaling activation enhances the potency of human pluripotent stem cell-derived eosinophils in cancer immunotherapy for solid tumors","volume":"14","author":"Zhu","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.xcrm.2026.102992_bib106","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.stemcr.2021.06.005","article-title":"Human pluripotent stem cell-derived eosinophils reveal potent cytotoxicity against solid tumors","volume":"16","author":"Lai","year":"2021","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102992_bib107","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s42255-022-00713-7","article-title":"Implantation underneath the abdominal anterior rectus sheath enables effective and functional engraftment of stem-cell-derived islets","volume":"5","author":"Liang","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.xcrm.2026.102992_bib108","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1016\/j.cell.2024.09.004","article-title":"Transplantation of chemically induced pluripotent stem-cell-derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient","volume":"187","author":"Wang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102992_bib109","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S2213-8587(25)00423-1","article-title":"Autologous and allogeneic stem cell-derived islet therapy in three recipients with type 1 diabetes and complete loss of endogenous pancreatic beta-cell function pretransplant","volume":"14","author":"Shi","year":"2026","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.xcrm.2026.102992_bib110","article-title":"Epigenetic restoration of differentiation competency via reversal of epiblast regionalisation","author":"Sutcliffe","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2026.102992_bib111","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nmeth.3507","article-title":"Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells","volume":"12","author":"Paull","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2026.102992_bib112","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1172\/JCI130767","article-title":"Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson's disease models","volume":"130","author":"Song","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102992_bib113","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/978-3-319-75402-4_77","article-title":"Validation of iPS Cell-Derived RPE Tissue in Animal Models","volume":"1074","author":"Khristov","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.xcrm.2026.102992_bib114","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1182\/blood.2022017296","article-title":"iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study","volume":"140","author":"Sugimoto","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.102992_bib115","doi-asserted-by":"crossref","DOI":"10.1177\/09636897241290367","article-title":"Human Stem Cell-Derived Cardiomyocytes Integrate Into the Heart of Monkeys With Right Ventricular Pressure Overload","volume":"33","author":"Scholz","year":"2024","journal-title":"Cell Transplant."},{"key":"10.1016\/j.xcrm.2026.102992_bib116","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3171\/2024.4.JNS24367","article-title":"Preclinical evaluation of transaxial intraputaminal trajectory for enhanced distribution of grafted cells in Parkinson's disease","volume":"141","author":"Emborg","year":"2024","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.xcrm.2026.102992_bib117","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fncel.2020.00058","article-title":"Advantages and Recent Developments of Autologous Cell Therapy for Parkinson's Disease Patients","volume":"14","author":"Osborn","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.xcrm.2026.102992_bib118","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(24)01764-1","article-title":"Induced pluripotent stem-cell-derived corneal epithelium for transplant surgery: a single-arm, open-label, first-in-human interventional study in Japan","volume":"404","author":"Soma","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2026.102992_bib119","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.1182\/blood-2024-198684","article-title":"Safety and efficacy of FT522, a first-in-class, multi-antigen targeted, off-the-shelf, iPSC-Derived CD19 CAR NK cell therapy with alloimmune defense receptor (ADR) in Relapsed\/Refractory B-Cell lymphoma","volume":"144","author":"Bachanova","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.102992_bib120","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2604408","article-title":"Long-Term Survival of Hypoimmune Allogeneic Islets without Immunosuppression","author":"Carlsson","year":"2026","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102992_bib121","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.stem.2020.07.004","article-title":"Universal Stem Cells: Making the Unsafe Safe","volume":"27","author":"Harding","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.102992_bib122","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41577-019-0200-1","article-title":"Engineering universal cells that evade immune detection","volume":"19","author":"Lanza","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.102992_bib123","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.stem.2025.03.008","article-title":"A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models","volume":"32","author":"Pavan","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.102992_bib124","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-026-04975-w","article-title":"Comprehensive assessment of the genomic stability of human induced pluripotent stem cells for clinical applications","volume":"17","author":"Zhang","year":"2026","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.xcrm.2026.102992_bib125","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/nbt.2051","article-title":"Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage","volume":"29","author":"Amps","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102992_bib126","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature22312","article-title":"Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations","volume":"545","author":"Merkle","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102992_bib127","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nbt.1835","article-title":"Karyotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells","volume":"29","author":"Taapken","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102992_bib128","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","article-title":"Identification of preexisting adaptive immunity to Cas9 proteins in humans","volume":"25","author":"Charlesworth","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102992_bib129","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1038\/s41467-018-05843-9","article-title":"Cas9 immunity creates challenges for CRISPR gene editing therapies","volume":"9","author":"Crudele","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102992_bib130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13287-015-0167-1","article-title":"The immune response of stem cells in subretinal transplantation","volume":"6","author":"Xian","year":"2015","journal-title":"Stem Cell Res. Ther."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266637912600409X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266637912600409X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:11:36Z","timestamp":1792509096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266637912600409X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":129,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S266637912600409X"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102992","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The evolution of iPSC-based cell therapy across autologous and allogeneic pathways","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102992","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102992"}}